Tracking and addressing emerging infectious diseases in emergency departments.
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
This study is looking at how common new infectious diseases are and what factors might increase the risk, especially in diverse communities, by collecting health information from patients visiting emergency rooms across the U.S., so we can better support doctors and improve public health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11014935 on NIH RePORTER |
What this research studies
This research focuses on monitoring and understanding emerging infectious diseases by collecting clinical data and specimens from patients who present to emergency departments across the United States. It aims to assess the prevalence of these diseases, identify risk factors, and evaluate management practices, particularly among diverse and underserved populations. The project utilizes a network established by the CDC to conduct real-time surveillance and has previously demonstrated its effectiveness during the COVID-19 pandemic. By analyzing this data, the research seeks to inform public health policies and improve physician practices.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients presenting with acute illnesses in emergency departments, particularly those from diverse and underserved communities.
Not a fit: Patients with chronic conditions or those not presenting with acute infectious symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved detection and management of emerging infectious diseases, ultimately enhancing patient care and public health responses.
How similar studies have performed: Previous research efforts using similar surveillance approaches have shown success, particularly during the COVID-19 pandemic, indicating the potential effectiveness of this methodology.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Talan, David Andrew — University of California Los Angeles
- Study coordinator: Talan, David Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.